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CD1 molecules are nonpolymorphic MHC 
class I–like proteins that associate with β2-
  microglobulin and present lipids and glycolipids 
to the immune system. Mammalian CD1 pro-
teins segregate into group I (CD1a, CD1b, and 
CD1c) and group II (CD1d) based on sequence 
homologies (1, 2). Mice express CD1d only. 
Its distribution is limited to macrophages, mon-
ocytes, B cells, DCs, and cortical thymocytes 
(3, 4). CD1d is the restriction element for two 
groups of T cells that recognize lipids. The fi  rst 
group is indistinguishable from classic T cells 
and has been identifi  ed in humans for lipids 
as diverse as mycobacterial mycolic acids and 
endogenous sulfatide (5–7). The second group 
represents a unique, small population of T cells 
called NK T cells (NKT cells) that is essential 
for the regulation of immune responses (8). 
NKT cells represent an ideal system for the 
study of lipid antigens because agonist ligands 
such as α-galactosyl and α-glucuronosyl ce-
ramides have been identifi  ed, and the main 
thymic selecting ceramide, isoglobotrihexosyl-
ceramide (iGb3), is known (9, 10). NKT cells 
express a unique TCR-α chain (Vα14-Jα18 
in the mouse and Vα24-Jα18 in the human) 
paired with a restricted set of Vβ segments (Vβ8, 
Vβ7, and Vβ2 in the mouse and Vβ11 in the 
human; references 11, 12).
Unlike conventional αβ T cells, NKT cells 
are selected by CD4+CD8+ cortical thymo-
cytes, not by epithelial cells (12, 13). This selec-
tion process requires the intracellular traffi   cking 
of CD1d to late endosomal and lysosomal 
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The Niemann-Pick type C2 (NPC2) protein is a small, soluble, lysosomal protein important 
for cholesterol and sphingolipid transport in the lysosome. The immunological phenotype of 
NPC2-defi  cient mice was limited to an impaired thymic selection of V𝗂14 natural killer 
T cells (NKT cells) and a subsequent reduction of NKT cells in the periphery. The remaining 
NKT cells failed to produce measurable quantities of interferon-𝗄 in vivo and in vitro after 
activation with 𝗂-galactosylceramide. In addition, thymocytes and splenocytes from NPC2-
defi  cient mice were poor presenters of endogenous and exogenous lipids to CD1d-restricted 
V𝗂14 hybridoma cells.
Importantly, we determined that similar to saposins, recombinant NPC2 was able to 
unload lipids from and load lipids into CD1d. This transfer activity was associated with 
a dimeric form of NPC2, suggesting a unique mechanism of glycosphingolipid transfer by 
NPC2. Similar to saposin B, NPC2 dimers were able to load isoglobotrihexosylceramide (iGb3), 
the natural selecting ligand of NKT cells in the thymus, into CD1d. These observations 
strongly suggested that the phenotype observed in NPC2-defi  cient animals was directly 
linked to the effi  ciency of the loading of iGb3 into CD1d molecules expressed by 
  thymocytes. This conclusion was supported by the rescue of endogenous and exogenous 
iGb3 presentation by recombinant NPC2. Thus, the loading of endogenous and exogenous 
lipids and glycolipids onto CD1d is dependent on various small, soluble lipid transfer 
proteins present in the lysosome.
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  compartments (14). The main endogenous self-glycolipid 
that, once bound to CD1d, selects canonical Vα14 NKT 
cells was recently identifi  ed as iGb3, a sphingolipid that is 
produced in small quantities by iGb3 synthases and mainly by 
the degradation of isoglobotetrahexosylceramide by glycosi-
dase β–hexosaminidase b, as illustrated by the absence of 
Vα14 NKT cells in hexosaminidase b–defi  cient mice (10, 15). 
We have shown in vitro and in vivo that iGb3 could not 
load CD1d spontaneously but rather required the assistance 
of lipid transfer proteins (LTPs) such as saposin (10). The 
number of known lysosomal LTPs is limited, and their main 
members are saposins A–D, GM2 activator (GM2a), and 
Niemann-Pick type C2 (NPC2; references 16–18). The overlap 
of transfer activity between these diff  erent molecules is rather 
large, as they all bind similar glycolipids such as gangliosides 
(19, 20). However, each has its own specifi  city and profi  le, as 
exemplifi  ed by the capacity of saposin B and GM2a to trans-
fer αGalCer to CD1d and the inability or low activity of any 
of the other saposins to do so (reference 21; unpublished data). 
This situation suggested to us that in the lysosome, the reper-
toire of lipid bound to CD1 could be the result of glycolipid 
loading by multiple LTPs.
NPC2 is a 22-kD soluble lysosomal glycoprotein that is 
expressed ubiquitously and secreted as a mannose-6-phos-
phate–tagged protein (22, 23). NPC2 is the only small LTP 
that has been identifi  ed consistently in the lysosomal pro-
teome next to saposin (17, 18). NPC2 binds and transfers 
cholesterol, but its precise function is still undefi  ned (24). Its 
defi  ciency leads to a small ( 5%) complementation group of 
Niemann-Pick disease, which is clinically indistinguishable 
from Niemann-Pick type C1 (NPC1) defi  ciency (25, 26). 
The identical phenotype is rather surprising, as evidence has 
accumulated to demonstrate that there are no physical rela-
tionships between the two molecules (17, 27, 28).
However, immunological phenotypes appear to be suffi   -
ciently subtle to attribute specifi  c functions to both NPC1 
and NPC2 and separate the two complementation groups. 
We have recently reported that NPC1-defi  cient mice lacked 
Vα14 NKT cells and that this phenotype was linked to an 
abnormal traffi   cking of sphingolipid antigens to the lysosome, 
which is secondary to a late endosomal block/accumulation 
(29). In the present study, we investigated the impact of a 
defi  ciency in NPC2 production with respect to Vα14 NKT 
development and functions. As for NPC1-defi  cient mice, the 
NPC2-defi  cient animal exhibited an important reduction of 
Vα14 NKT cell numbers, and the presentation of endoge-
nous and exogenous lipid antigens by NPC2-defi  cient thy-
mocytes and splenocytes was substantially reduced. However, 
in contrast to NPC1 defi  ciency, NPC2 absence did not lead 
to a noticeable late endosomal block of lipid traffi   cking to the 
lysosome. Antigen presentation defi  ciency was reversed by 
the addition of exogenous recombinant NPC2. In vitro, 
NPC2 was able to load iGb3 into CD1d molecules, and only 
dimers of the molecule were able to transfer iGb3 and other 
glycolipids to CD1, arguing that cholesterol and sphingolipid 
transfers by NPC2 might operate diff  erently. Our data indicate 
that NPC2 participates in the loading of endogenous lipids 
into CD1d and in the selection of NKT cells. Therefore, 
as suggested in this study, multiple lysosomal LTPs can oper-
ate to establish the repertoire of lipids to be presented to the 
immune system.
RESULTS
NPC2-defi  cient mice exhibit a reduction of V𝗂14 NKT cells
Thymocytes, splenocytes, and hepatic and blood lympho-
cytes from 7-wk-old NPC2−/− or littermate control mice 
were stained with CD1d-αGalCer tetramers. On the BALB/c 
background, the proportion of tetramer-positive cells in 
NPC2-defi  cient mice was dramatically reduced in all tissues 
(Fig. 1 A). In the spleen and liver, the tetramer-positive cells 
represented 18% and 20%, respectively, of the population ob-
served in the WT littermate control (Fig. 1 A). In the thy-
mus, tetramer and antibody staining distinguished two subsets 
of NKT cells: a resident thymic population (CD1d-αGalCer 
tetramerintermediate, CD44high, CD49b+) and a larger popula-
tion of cells that will immigrate to the periphery (CD1d-
αGalCer tetramerhigh, CD44intermediate, CD49b−; Fig. S2; 
references 30, 31). NPC2 defi  ciency was accompanied by 
an almost complete disappearance of the CD1d-αGalCer 
tetramerhigh CD44int population (2% of the littermate control 
population) that persisted over time (Fig. 1 B), whereas the 
CD1d-αGalCer tetramerint CD44high population was reduced 
to 25% early on (Fig. 1 A) but accumulated intrathymically to 
reach normal levels at 12 wk (Fig. 1 B). The Vα14 NKT cell 
selection defect was specifi  c for Vα14 NKT cells because the 
thymus and the spleen of NPC2-defi  cient mice exhibited 
normal numbers of CD4, CD8, and B cells (Fig. S1, available 
at http://www.jem.org/cgi/content/full/jem.20061562/DC1). 
Identical results were obtained from NPC2 mice bred on the 
mixed B6/129 background (unpublished data).
These results indicate that there is a selective decrease in 
the thymic selection, a normal emigration to the periphery, 
and a small but noticeable expansion in the periphery of 
Vα14 NKT cells in the absence of NPC2 protein. The pro-
gressive accumulation of the resident thymic NKT cell popu-
lation was reproducible but never led to increased numbers in 
the periphery in any of the older animals, clearly separating 
the behavior of these two populations.
The remaining population of NKT cells in NPC2−/− animals 
has limited functionality
The addition of the increasing concentration of αGalCer 
and Galα1-2GalCer to whole spleen cells leads to an NKT 
cell–dependent production of IFN-γ (32, 33). As expected, 
NPC2−/− NKT cells failed to produce or induce the produc-
tion (through NK stimulation; reference 34) of a detectable 
amount of IFN-γ with either lipid (Fig. 2 A) in this assay, as 
they also did in vivo after i.v. injection of 2 μg αGalCer 
(Fig. 2 B). In this latter instance, a very limited NKT cell 
expansion was noticeable 6 d after the injection of αGalCer 
and was comparable with the WT when expressed as fold 
expansion using day 0 as a reference (Fig. 2, C and D). JEM VOL. 204, April 16, 2007  843
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This result strongly argued that the IFN-γ phenotype was 
linked to antigen presentation rather than to an inherent 
NKT cell dysfunction. A more detailed analysis of CD1d-
restricted antigen presentation was undertaken in vitro.
Defective presentation of endogenous and exogenous 
lipid antigens by thymocytes and splenocytes 
from NPC2-defi  cient mice
The expression of CD1d molecules was normal in NPC2−/− 
animals on all cellular subsets tested, especially B cells, DCs, 
and thymocytes, excluding a functional knockout of CD1d 
and a subsequent NKT cell defi   ciency (Fig. S3, available 
at http://www.jem.org/cgi/content/full/jem.20061562/DC1). 
The antigen-presenting capacities of CD1d-expressing cells 
from defi  cient animals were then evaluated in vitro by using 
the classic DN32.D3 assay (21). This assay appreciates the 
  expression of CD1d–iGb3 complexes in tissues by testing 
the capacity of primary cells such as thymocytes to stimulate 
the production of IL-2 from Vα14-DN32.D3 T cell 
  hybridoma cells in the absence of exogenous antigen. Simi-
lar to the situation encountered in the absence of CD1d 
  expression, NPC2−/− thymocytes were unable to stimulate 
DN32.D3 cells (Fig. 3 A). In contrast, the non-Vα14 NKT 
hybridoma TBD7 was responding identically to NPC2−/− 
and WT thymocytes, whereas the stimulation of TCB11 was 
reduced by  50% in the absence of NPC2 (Fig. 3 B). These 
results suggested that NPC2 defi  ciency specifi  cally impaired 
the presentation of iGb3 by CD1d-expressing thymocytes 
Figure 1.  NPC2-defi  cient mice exhibit a reduction of NKT cells. 
(A) Vα14 NKT cells from the thymus, liver, spleen, and blood of 7-wk-old 
WT or NPC2-defi  cient (NPC2−/−) mice were stained with CD1d-αGalCer 
tetramers and CD44 or TCR-β. The values in the gates indicate the absolute 
numbers of Vα14 NKT cells as represented by their percentages of the 
lymphocyte population in each organ. For the thymus, percentages are 
split in CD1d-αGalCer tethigh CD44int and CD1d-αGalCer tetint CD44high 
cells. Percentages in the liver are percentages out of all lymphocytes. The 
fi  gure is representative of two independent experiments with two animals 
in each group. (B) Age-related variations of NKT cell numbers. Thymocytes 
from 3-, 7-, and 12-wk-old WT and NPC2−/− mice were stained with 
CD1d-αGalCer tetramer and anti-CD44 antibody. Percentages of CD1d-
αGalCer tethigh CD44int and CD1d-αGalCer tetint CD44high cells are indi-
cated in the gates. The numbers of animals analyzed per group are 
four, two, and fi  ve for 3 wk, 7 wk, and 12 wk, respectively. Cellularity 
of the thymus of NPC2−/− animals was normal at 3 and 7 wk and 
 diminished  by   30% at 12 wk of age (70.5 ± 27%) as compared 
with littermate controls.844  NIEMANN-PICK TYPE C2 PROTEIN AND NKT CELLS | Schrantz et al.
but not (or only partially) the presentation of some other en-
dogenous lipids.
The presentation of exogenous lipids was tested with 
αGalCer and Galα1-2GalCer, two agonists of NKT cells that 
are partially and completely dependent on endosomal func-
tions, respectively (33). Stimulation of DN32.D3 by thymo-
cytes and splenocytes from NPC2−/−-defi  cient mice pulsed 
with αGalCer was decreased and similar to presentation by 
CD1d−/− cells, whereas the processing/presentation of Galα1-
2GalCer was abolished (Fig. 3, C and D). The presentation by 
BM-derived DCs (BMDCs) of these same two lipids was only 
marginally aff  ected (Fig. 3 E). This same phenotype of lipid 
presentation defi  ciency was found throughout the life of the 
NPC2−/− animals, as we tested mice of 3, 6, 8, 9, 10, 13, and 
14 wk of age.
These results demonstrated that thymocytes and spleno-
cytes that both express similar amounts of NPC2 in the WT 
(Fig. S4, available at http://www.jem.org/cgi/content/full/
jem.20061562/DC1) required NPC2 for the presentation of 
exogenous lipids. This specifi  c defi  cit argued that the absence 
of NPC2 did not grossly aff  ect the CD1d/lipid-loading com-
partments. This functionality of the late endosomal/lysosomal 
compartments was confi  rmed by testing the presentation of 
MHC class II–restricted proteins such as OVA. D011.10 T 
cell hybridoma cells that recognize the OVA peptide 323–339 
in the context of I-Ab/d were stimulated normally by NPC2−/− 
splenocytes incubated with intact OVA (Fig. 3 F).
Traffi  cking of glycosphingolipids in NPC2-defi  cient cells
Confocal microscopic analysis of splenocytes from WT and 
NPC2−/− mice showed that CD1d was normally localized 
in the lysosome-associated membrane protein 1–positive late 
endosome/lysosome compartment of NPC2−/− cells (Fig. 4 A), 
where lipid antigens are loaded in CD1d (35). Abnormal 
lipid traffi   cking in NPC1−/− cells has been extensively docu-
mented (22, 36, 37). Because of cholesterol accumulation 
in the endosomal pathway, the transport of lactosylceramide 
(LacCer) to the Golgi is heavily disturbed, and fl  uorescent 
forms of αGalCer accumulate in the late endosome without 
ever reaching the lysosome (29). Similar studies on NPC2−/− 
cells are scarce and poorly documented. Fluorescent LacCer 
was fed to WT and NPC2−/− fi  broblasts for 30 min and 
observed by confocal microscopy on live cells after a 90-min 
chase (Fig. 4 B). WT and mutant cells looked very similar, 
with a predominant distribution of LacCer to the Golgi 
apparatus (Fig. 4 B). In addition to Golgi staining, some 
NPC2−/− cells exhibited small vesicular staining reminis-
cent of LacCer distribution in NPC1−/− cells (29, 38), indi-
cating some minor defects in endosomal transport, as would 
be expected.
The accumulation of cholesterol and gangliosides in cells 
was analyzed by fl  ow cytometry by measuring the accumu-
lation of Lysotracker green after a short pulse of ingestion 
(39). The storage of lipids in NPC2−/− cells was more im-
portant in splenocytes and BMDCs than in thymocytes and 
Figure 2.  In vivo and in vitro functional analysis of V𝗂14 NKT 
cells. (A) Splenocytes from WT (closed symbols) or NPC2−/− (open symbols) 
were cultured with various concentrations of αGalCer (squares) or 
Galα1-2αGalCer (circles), and IFN-γ production in culture supernatants 
was measured by ELISA. (B) WT (closed squares) and NPC2−/− (open 
squares) mice were injected i.v. with 2 μg αGalCer, and the production 
of IFN-γ in serum was measured by ELISA. (C and D) 2 μg αGalCer was 
injected i.v. to WT (closed squares) and NPC2−/− (open squares) mice. 
The expansion of Vα14 NKT cells was followed in blood at different time 
points by staining peripheral blood lymphocytes with CD1d-αGalCer 
  tetramer and anti–TCR-β antibody and was expressed as a percentage 
of lymphocytes (C) or fold increase using day 0 as a reference (D). All 
experiments were performed twice with two animals per group. Error 
bars represent SD.JEM VOL. 204, April 16, 2007  845
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Figure 3.  Defective presentation of endogenous and exogenous 
lipid antigens by thymocytes and splenocytes from NPC2-defi  cient 
mice. (A and B) IL-2 production by DN32.D3 hybridoma T cells (A) and 
non-Vα14 hybridoma TCB11 (gray) and TBD7 (black; B) cultured with 
  thymocytes from NPC2−/−, WT, and CD1d−/− mice. Data are representative 
of three independent experiments. (C–E) Presentation of αGalCer and 
Galα1-2GalCer by thymocytes (C), splenocytes (D), and BMDCs (E) from 
WT (closed squares) and NPC2−/− (open squares) mice. Data are represen-
tative of four independent experiments using mice between the ages of 
6 and 9 wk. (F) Presentation of OVA protein by splenocytes from WT 
(closed squares) and NPC2−/− (open squares) mice to DO11.10 T cell hy-
bridoma. IL-2 was measured at 24 h. Data are representative of two inde-
pendent experiments. Error bars represent SD.846  NIEMANN-PICK TYPE C2 PROTEIN AND NKT CELLS | Schrantz et al.
fi  broblasts when compared with the WT (Fig. 4 C). Because 
BMDCs and splenocytes were discordant for their presenta-
tion phenotype, we can conclude that there is no correlation 
between the degree of lysosomal lipid accumulation and lipid 
antigen presentation. The same profile of lysosomal accu-
mulation in NPC2−/− cells was demonstrated for cholesterol 
using fi  lipin staining (Fig. S5, available at http://www.jem
.org/cgi/content/full/jem.20061562/DC1).
The overall normal transport and localization of glyco-
sphingolipids in NPC2−/− cells was confi  rmed by examining 
the uptake and intracellular traffi   cking of a fl  uorescent-
labeled derivative of αGalCer (BODIPY-αGalCer and PBS-
81) in fi  broblasts and splenocytes. Cells were pulsed for 5 h 
(Fig. S6, available at http://www.jem.org/cgi/content/full/
jem.20061562/DC1) or overnight with PBS-81 and the ly-
sosomal marker Lysotracker red and observed by confocal 
microscopy. PBS-81 accumulated in small peripheral trans-
port vesicles and lysosomes, where they costained with the 
lysosomal dye. This pattern was indistinguishable between 
WT and NPC2-defi  cient cells (Fig. 4, D and E) even though 
the lysosomal compartment of NPC2−/− cells was consis-
tently larger. Similar results were observed in BMDCs (unpub-
lished data). These results indicated that unlike NPC1-defi  cient 
cells, NPC2-defi  cient cells exhibited a relatively normal up-
take and traffi   cking of Vα14 NKT cell ligands through the 
endosomal compartments and to the lysosome, where they 
could be loaded into CD1d.
In vitro transfer of lipids to CD1d molecules by NPC2 
recombinant molecules
Recombinant mouse NPC2 was produced in a fl  y expression 
system and purifi  ed by a succession of nickel–nitrilotriacetic 
acid (NTA) agarose, cation, and gel fi  ltration chromato-
graphies (40). This protocol allowed the separation of mono-
mers and nondisulfi  de-linked dimers of NPC2 (Fig. 5 A). 
The dimeric form of mouse NPC2 was also observed after 
expression in HeLa cells (Fig. 5 B). Like human NPC2 protein 
expressed in Chinese hamster ovary cells (41), fl  y-expressed 
Figure 4.  Traffi  cking of glycosphingolipids in WT and NPC2−/− 
cells. (A) Splenocytes were analyzed by confocal fl  uorescence microscopy 
for Lamp-1 (green) and CD1d (red). Individual green and red channels 
as well as the overlay are presented. (B) BM-derived primary fi  broblasts 
from WT and NPC2−/− mice were pulsed with BODIPY-LacCer (green) and 
observed by confocal microscopy. (C) Evaluation of the late endosomal/
lysosomal compartment size in WT and NPC2−/− cells. Thymocytes, sple-
nocytes, BMDCs, and BM-derived fi  broblasts from WT or NPC2−/− mice 
were stained with Lysotracker, and the fl  uorescence of the cells was 
  analyzed by fl  ow cytometry. Unstained (green), WT (red), and NPC2−/− (blue) 
profi  les are presented. (D) Primary fi  broblasts from WT and NPC2−/− mice 
were pulsed overnight with BODIPY–PBS-81 (green) and Lysotracker red 
(red) the next day and observed by confocal microscopy. Individual green 
and red channels as well as the overlay are presented. (E) Splenocytes 
were pulsed overnight with BODIPY–PBS-81 (green) and Lysotracker red 
(red) the next day and observed by confocal microscopy. Individual green 
and red channels as well as the overlay are presented. Bars (A), 5 μm; 
(B and D) 10 μm; (E) 2 μm.JEM VOL. 204, April 16, 2007  847
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mouse NPC2 protein was able to bind the fl  uorescent cho-
lesterol analogue dehydroergosterol (DHE; Fig. 5 C). Inter-
estingly, NPC2 dimers and monomers were able to bind 
DHE similarly (Fig. 5 C). Using a cell-free assay, we tested 
the ability of NPC2 dimers and monomers to transfer 
GM3 into CD1d (10, 21, 42). In the absence of NPC2, 
GM3 was poorly loaded onto CD1d. In the presence of di-
mers but not monomers of NPC2, the loading of GM3 
into CD1d was substantially increased (Fig. 5 D). The load-
ing of GM3 into CD1d by dimers of NPC2 was not modi-
fi   ed by the presence of cholesterol (unpublished data). 
Using CD1d molecules loaded with GT1b, we analyzed the 
ability of NPC2 to unload GT1b from CD1d–GT1b com-
plexes. Again, only NPC2 dimers were able to unload GT1b 
from CD1d (Fig. 5 E).
A similar situation was encountered when we tested the 
ability of NPC2 to load iGb3 into CD1d (Fig. 5 F). So far, in 
vitro, only saposin B had been shown to transfer iGb3 effi   -
ciently to CD1d, but recombinant NPC2 was effi   cient in 
carrying this function. This result suggests that both LTPs 
might act in the lysosome to load natural ligands into CD1d 
and select NKT cells.
Recombinant NPC2 protein enhances the presentation 
of ligands to V𝗂14 NKT cells
NPC2 accesses the lysosome after secretion through cellu-
lar uptake by the mannose-6-phosphate receptor (23). To 
evaluate the capacity of recombinant NPC2 to increase the 
uptake and loading of exogenous lipids into CD1d, WT and 
NPC2−/− splenocytes were pulsed with iGb3 in the presence 
Figure 5.  Oligomerization of NPC2 and in vitro loading and 
unloading of lipids into and from CD1d by recombinant NPC2. (A) Gel 
fi  ltration profi  le and Coomassie blue gel of purifi  ed recombinant NPC2 
protein. Fractions containing monomers and enriched in NPC2 dimers are 
indicated (arrows in the profi  le; monomers [m] and dimers [d] in the gel). 
(B) Expression of NPC2 in HeLa cells. Lysates from transfected HeLa cells 
were boiled in the presence of SDS or left untreated and analyzed by 
Western blotting using anti-Flag antibody. (C) Interaction of fl  y-expressed 
NPC2 protein with DHE. Fluorescent spectra of samples containing 10 μM 
NPC2 monomer (NPC2m) and 10 μM NPC2 dimer (NPC2d) with or with-
out 1 μM DHE. Spectra of samples containing buffer or 1 μM DHE only 
are also shown. (D) 2.5 μM CD1d–GT1b complexes were incubated with 
increasing concentrations of GM3 in the absence (white bars) or presence 
of 50 μM NPC2 dimers (gray bars) or 50 μM NPC2 monomers (black 
bars). The percentage of GM3 loading is indicated. (E) 2.5 μM CD1d–GT1b 
complexes were incubated with increasing concentrations of NPC2 mono-
mers (white bars) and dimers (black bars). Unloading is indicated as a 
percentage of GT1b removal. (F) NPC2 dimers load iGb3 into CD1d. 2.5 μM 
CD1d–GT1b complexes were incubated with increasing concentrations of 
NPC2 dimers in the absence or presence of 20 μM iGb3 C18 (iGb3). Lipid 
unloading and loading were visualized by native IEF. Relative positions of 
CD1d, CD1d–GT1b, and CD1d–iGb3 are indicated by arrows. Error bars 
represent SD.848  NIEMANN-PICK TYPE C2 PROTEIN AND NKT CELLS | Schrantz et al.
or absence of recombinant NPC2 and were used to stimu-
late DN32.D3 hybridoma cells. WT splenocytes presented 
iGb3 to DN32.D3 hybridoma with a typical dose/response 
curve (Fig. 6 A), whereas NPC2−/− splenocytes presented 
only the highest concentration of iGb3 (Fig. 6 B). The ad-
dition of recombinant NPC2 slightly increased the presenta-
tion of iGb3 by WT splenocytes and established normal levels 
of stimulation by NPC2-defi  cient cells (Fig. 6, A and B). This 
eff  ect required CD1d, as cells from CD1d−/− mice could not 
stimulate DN32.D3 cells in the presence of recombinant NPC2 
(unpublished data). The addition of recombinant GM2a, 
which was produced in the same expression system, did not 
rescue the phenotype, confi  rming the speci  fi  city of the eff  ect 
(Fig. S7, available at http://www.jem.org/cgi/content/full/
jem.20061562/DC1).
Similarly, in the absence of exogenous lipid, the addition 
of recombinant NPC2 to NPC2−/− thymocytes restored the 
presentation of endogenous lipids, as illustrated by the stimu-
lation of DN32.D3 cells (Fig. 6 C). The same addition of re-
combinant NPC2 to WT thymocytes slightly increased their 
stimulatory activity (Fig. 6 C). The addition of recombinant 
GM2a, which was produced and purifi  ed similarly, did not 
rescue the phenotype or alter presentation (Fig. 6 C). Rescue 
of the antigen presentation phenotype of NPC2−/− cells by 
the addition of recombinant NPC2 directly demonstrates 
the role of NPC2 in the presentation of endogenous and exo-
genous lipids.
D  I  S  C  U  S  S  I  O  N 
The selection of Vα14 NKT cells in the thymus is dependent 
on the expression of iGb3–CD1d complexes by cortical thy-
mocytes. Presentation of the endogenous iGb3 by CD1d 
molecules requires the presence of iGb3 in the lysosomes and 
its assisted loading into CD1d by LTPs. We previously showed 
that the impaired production of iGb3 or the lack of saposins 
resulted in the severe defi  ciency or lack of Vα14 NKT cells 
(10, 21). In an attempt to fi  nd other lysosomal LTPs involved 
in the loading of lipid antigens into CD1d, we investigated 
whether NPC2 could play a role in Vα14 NKT cell selection 
and lipid antigen presentation.
Our study establishes that a defi  ciency in NPC2 pro-
foundly aff  ects the numbers of Vα14 NKT cells in the thy-
mus and peripheral tissues. It is important to notice that this 
phenotype was observed in mice and cells that have some re-
sidual NPC2 activity (27) and that a complete knockout of 
expression would likely reinforce the traits that we observed. 
The thymic phenotype reveals two pieces of information: 
(a) NPC2 is required for the normal selection of Vα14 NKT 
cells, and (b) the resident thymic population is similarly af-
fected, suggesting similar selecting ligands, but has the capacity 
to accumulate over time, indicating that it behaves diff  erently 
from peripheral NKT cells. NPC2 is not involved in the egress 
of NKT cells from the thymus as they are found in the pe-
riphery. However, the small number of exported immature 
NKT cells does not lead to a normal peripheral compartment 
Figure 6.  Exogenous NPC2 protein enhances the presentation of 
lipids by splenocytes and thymocytes from WT and NPC2−/− mice. 
(A and B) Splenocytes from WT (A) or NPC2−/− (B) mice were pulsed in the 
absence (white symbols) or presence of 10 (gray symbols) or 20 μg/ml 
(black symbols) NPC2 and increasing concentrations of iGb3 C18 (iGb3) for 
4 h and were incubated with DN32.D3. IL-2 production was measured at 
24 h. Data are representative of two independent experiments. (C) Thymo-
cytes from WT and NPC2−/− mice were incubated for 24 h in the absence 
or presence of 10 or 20 μg/ml NPC2 or GM2a and with DN32.D3 T cells. 
Data are representative of two independent experiments. Error bars 
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through expansion, as the defi  cit remains severe throughout 
the life of these animals.
The delay observed in the expansion of peripheral NKT 
cells in NPC2−/− animals suggests that in these mice, mainly 
DCs present αGalCer to Vα14 NKT cells, as it is known that 
the injection of αGalCer-pulsed DCs induces a delayed ex-
pansion of Vα14 NKT cells and cytokine production as 
compared with the injection of αGalCer alone (43). In 
  addition, the normal degree of expansion of Vα14 NKT 
cells in NPC2−/− mice suggests that NPC2 defi  ciency does 
not aff  ect the function of Vα14 NKT cells but only anti-
gen presentation.
The defect of the presentation of exogenous glycosphin-
golipid such as αGalCer and Galα1-2αGalCer by NPC2-
defi  cient splenocytes and thymocytes, whereas the presentation 
of these same lipids by BMDCs was only slightly aff  ected, in-
dicates that the LTP requirements for exogenous lipid uptake 
and presentation are diff  erent between various cell types. It 
also strongly suggests a model in which multiple LTPs shape 
the repertoire of lipid presented by CD1d molecules. This 
hypothesis is also supported by the profi  le of stimulation of 
non-Vα14 NKT cells by NPC2−/− cells. Although TCB11 
stimulation was normal, TBD7 stimulation was partially af-
fected. We have not encountered this discrepant phenotype in 
prosaposin-defi  cient animals and GM2a−/− mice in which 
both stimulations were normal (references 10, 21; unpub-
lished data). The almost normal presentation of lipids by DCs 
derived from NPC2−/− mice also suggests that in vitro ma-
tured DCs do not faithfully represent some of the DC subsets 
present (for example, in the spleen). This situation will compel 
us to examine the presentation capacity of NPC2−/− DCs 
directly isolated and purifi  ed from spleen and lymph nodes to 
understand these discrepancies.
With respect to lipid traffi   cking, cholesterol and ganglio-
sides, including GM2 and GM3, have been shown to accu-
mulate in mice defi  cient in NPC1 (27, 38). In addition, the 
transport of BODIPY-LacCer to the Golgi and of fl  uorescent 
αGalCer to the lysosome in NPC1−/− cells has been shown 
to be heavily perturbed with the presence of a late endosomal 
block (29, 37, 38). A similar study in NPC2−/− cells has been 
very limited besides establishing that some cell types were ac-
cumulating cholesterol in the absence of NPC2 (44). More-
over, important diff  erences between NPC1−/− and NPC2−/− 
cells have been documented for the transport of GM2 gangli-
oside to the lysosome (45). Whereas NPC1−/− cells could not 
deliver GM2 to the lysosome, NPC2−/− cells could internal-
ize GM2 into endocytic vesicles and deliver it to the lysosome 
(45). Our evaluation of the transport of LacCer and PBS-81 
in NPC2−/− fi  broblasts and splenocytes is very much in agree-
ment with this observation. The transport of these two glyco-
lipids through the endocytic pathway appeared close to normal 
in most cells. A morphometric quantifi  cation of these results 
will allow us to appreciate the precise numbers of vesicles in 
which lysosomal markers and PBS-81 colocalize in WT and 
mutant cells and also to compare the impact of NPC2 defi  -
ciency in diff  erent cell types. These major diff  erences between 
NPC1−/− and NPC2−/− cells with respect to lipid endocyto-
sis and transport reinforce the idea that the two molecules are 
present in diff  erent compartments: late endosomes for NPC1 
and lysosomes for NPC2 (46, 47). This dichotomy could ex-
plain why NPC2 did not grossly perturb endocytosis and 
transport to the lysosome. However, the absence of NPC2 in 
the lysosome could aff  ect the egress of lipids from this com-
partment; this issue will need further inquiry.
Our initial assessment of the degree of lipid storage in 
various cell types by using lysosomal dyes showed that NPC2 
defi  ciency aff  ected mostly splenocytes and BMDCs, whereas 
thymocytes were only marginally perturbed. We can conclude 
from this observation that lipid accumulation and presenta-
tion phenotypes are not correlated. This dissociation is one 
additional argument against a nonspecifi  c eff  ect of lipid stor-
age as the cause for the observed phenotype resulting from the 
absence of NPC2.
Collectively, these observations suggest a direct role of 
NPC2 in the transport and loading of glycolipids into CD1d. 
The poor presentation of exogenous lipids and the almost 
complete absence of endogenous ligand presentation in 
NPC2−/− mice support this role, as does the in vitro loading 
of iGb3 into CD1d. However, the ability of recombinant 
NPC2 to complement the defi  cient phenotype is the most 
compelling argument supporting this hypothesis. In addi-
tion, the observation that only dimers of NPC2 are capable of 
transferring glycosphingolipids, whereas both dimers and 
monomers can bind cholesterol, suggests that the binding 
of cholesterol and the transfer of glycosphingolipids by NPC2 
are mechanistically diff  erent. The engineering of mutants of 
NPC2, which cannot form dimers, will help clarify this 
point further.
In summary, this study establishes that NPC2 is critical 
for the loading of iGb3 and exogenous lipids into CD1d. 
This observation suggests a model in which multiple LTPs 
present in the CD1d-containing compartments, such as sapo-
sin and NPC2, select the repertoire of CD1d-presented lipids 
and glycosphingolipids (17, 18). The polymorphism of NPC2 
will have to be studied in the context of NKT cells to deter-
mine whether pathological conditions are associated with 
variants of NPC2 that might aff  ect immune functions.
MATERIALS AND METHODS
Mice. NPC2- and CD1d-defi  cient mice have been described previously 
(27, 48). NPC2 mice have been backcrossed six times in the BALB/c back-
ground. NPC2-defi  cient mice and littermate controls were obtained by in-
tercrossing heterozygous mice. The genotype was determined by PCR as 
described previously (27). WT (NPC2+/+) and heterozygote (NPC2+/−) 
littermate mice were indistinguishable and are referred as WT. In all experi-
ments, WT age-matched littermate mice were used as a control. NPC2-
  defi  cient mice are hypomorph, expressing 4–5% of the normal levels of NPC2. 
Genetrap NPC2-defi  cient mice in a BL6 background were also analyzed 
(B6;129P2-Npc2Gt(pGT1TMpfs)1Ucd/Mmc; BayGenomics) and were indistinguish-
able from the hypomorph with respect to their immunological phenotype. 
All mice were bred at The Scripps Research Institute Animal Facility 
  according to Institutional Animal Care and Use Committee guidelines.
Cell culture. Fresh thymocytes, splenocytes, liver lymphocytes, and cultured 
BMDCs were obtained as described previously (32, 35). Primary fi  broblasts 850  NIEMANN-PICK TYPE C2 PROTEIN AND NKT CELLS | Schrantz et al.
were recovered from 7-d-old bone marrow culture by trypsination of the 
dish after washing out nonadherent cells. Cells were cultured in a 1:1 mix-
ture of Click’s medium and RPMI supplemented with 10% heat-inactivated 
FCS, glutamine, antibiotics, and 5 × 10−5 M β2- mercaptoethanol. Primary 
skin fi  broblasts were obtained by digesting mice skin with 1 mg/ml collagenase 
D (Roche) at 37°C in DMEM supplemented with 10% heat-  inactivated 
FCS for 5 h. After digestion, cells were washed several times in PBS and 
cultured in DMEM supplemented with 10% heat-inactivated FCS, gluta-
mine, antibiotics, and 5 × 10−5 M β2-mercaptoethanol.
Flow cytometry. CD1d-αGalCer tetramers were generated and used as 
described previously (40). FITC-conjugated anti-CD4, –TCR-β, and - CD44 
and allophycocyanin-conjugated anti-CD8 antibodies were purchased from 
BD Biosciences. Allophycocyanin-conjugated anti-B220 and -CD49b 
and PE–cyanin 7–conjugated anti-CD44 antibodies were obtained from 
eBioscience. Cells positive for propidium iodide and/or unloaded CD1d 
tetramer were excluded from analysis. Data were acquired using a fl  ow cy-
tometer (LSR2; Becton Dickinson) and analyzed using FACSDiva software 
(Becton Dickinson) and Flowjo software (Tree Star, Inc.). 106 events were 
typically recorded.
To evaluate lysosome size, thymocytes, splenocytes, BMDCs, and fi  -
broblasts from 6-wk-old WT or NPC2−/− mice were stained with 200 nM 
Lysotracker green (Invitrogen) for 10 min. After washing, cells were ana-
lyzed by fl  ow cytometry. Data were acquired using a FACSCalibur (Becton 
Dickinson) and Flowjo software. To evaluate cellular cholesterol content, 
cells from WT or NPC2−/− mice were fi  xed for 15 min with 4% parafor-
maldehyde, washed in Hanks’ balanced salt solution, and stained for 2 h at 
25°C with 100 μg/ml fi  lipin (Sigma-Aldrich) in Hanks’ balanced salt solution. 
Fluorescence emission was measured by fl  ow cytometry (49).
T cell hybridoma in vitro stimulation. APCs used in T cell hybridoma 
in vitro stimulation were obtained from NPC2−/− and WT littermate mice 
between 3 and 9 wk of age. To measure autoreactivity, DN32.D3, TCB11, 
and TBD7 NKT hybridomas (5 × 104 cells/well) were incubated in the 
presence of 5 × 105 fresh thymocytes for 24 h, and IL-2 released in cultured 
supernatants was measured using an IL-2–dependent NK cell line (21). 0.5 
μCi [3H]thymidine was added to each well after a 24-h incubation. Results 
are expressed as mean counts per minute of triplicates.
To study the presentation of exogenous lipids, fresh thymocytes or sple-
nocytes (5 × 104 cells/well) or 2 × 104 BMDCs were pulsed with or with-
out NPC2 and various concentrations of lipids for 4 h. After incubation, 
APCs were washed three times and incubated with DN32.D3 hybridoma 
cells (5 × 104 cells/well) for 24 h. IL-2 released in cultured supernatants was 
measured as described in the previous paragraph.
To study the eff  ect of recombinant NPC2 on autoreactivity, fresh thy-
mocytes (5 × 104 cells/well) were incubated with or without NPC2 and 
DN32.D3 hybridoma cells (5 × 104 cells/well) for 24 h. IL-2 released in 
cultured supernatants was measured as described above.
To study MHC class II–mediated antigen presentation, after irradiation, 
splenocytes were incubated for 24 h with various concentrations of OVA 
protein and the T cell hybridoma specifi  c for the peptide 323–339 of OVA 
in the context of I-Ad/I-Ab and DO11.10 (gift of S. Webb, The Scripps 
Research Institute, La Jolla, CA). IL-2 release in cultured supernatants was 
measured as described above. For whole spleen activation assay, fresh sple-
nocytes (5 × 105 cells/well) were cultured with various concentrations of 
lipids for 48 h. IFN-γ released in the culture supernatant was measured by 
ELISA (BD Biosciences).
Mice immunization. WT or NPC2-defi  cient mice were immunized by 
i.v. injection in the tail vein with 2 μg αGalCer diluted in PBS or with 
vehicle only. Blood was collected at diff  erent time points after immunization 
and used for NKT cell analysis or IFN-γ production quantifi  cation.
Synthesis of V𝗂14 NKT cell ligands. PBS-81 was synthesized as re-
ported previously for related compounds with the addition of the fl  uorophore 
(BODIPY FL; Invitrogen) at position six of the galactose via an amine (Fig. 
S8, available at http://www.jem.org/cgi/content/full/jem.20061562/
DC1; reference 50). To incorporate the fl  uorophore, the N-hydroxylsuc-
cinimicyl ester of 4,4-difl  uoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-
3-propionic acid (Invitrogen) was used. The structures of PBS-81 were 
confi  rmed by 1H and 13C nuclear magnetic resonance spectroscopy and 
mass spectrometry.
iGb3 C8 and iGb3 C18 were synthesized as reported previously (Fig. 
S8; references 10, 29), and C8 and C18 acyl chains, respectively, were used 
in place of a C26 chain. The structures of iGb3 C8 and IGb3 C18 were 
confi  rmed by 1H and 13C nuclear magnetic resonance spectroscopy and 
mass spectrometry.
Confocal microscopy. To study Vα14 NKT cell ligand traffi   cking, cells 
were grown on poly-l-lysine–coated coverslips (BD Biosciences) and incu-
bated for 5 h or overnight with 10 μM PBS-81 at 37°C. To stain lysosomes, 
primary fi  broblasts were incubated for 30 min with 1 μM Lysotracker red 
(Invitrogen), and splenocytes were incubated for 15 min with 0.1 μM Lyso-
tracker red. For LacCer traffi   cking, cells were incubated for 30 min at 37°C 
with 5 μm BSA-complexed BODIPY FL C5-LacCer (Invitrogen), washed 
three times with media, and incubated for 90 min at 37°C with media. Cells 
were washed three times with 2% FBS in PBS, and coverslips were mounted 
on slides with 2% FBS in PBS and a 1:50 dilution of oxyFluor (Oxyrase, 
Inc.). Live cells were examined immediately at room temperature by confo-
cal microscopy using a laser-scanning confocal microscope (MRC1024; 
Bio-Rad Laboratories) with a 63× plan-Apo 1.4 NA oil objective lens (Carl 
Zeiss MicroImaging, Inc.) and a krypton/argon mixed gas laser, which ex-
cites at 488, 568, and 647 nm and records simultaneously in three sepa-
rate channels.
To stain free cholesterol, cells were fi  xed with 4% paraformaldehyde for 
15 min at 25°C, washed with PBS, and stained with 50 μg/ml fi  lipin for 
30 min. Cells were washed and analyzed with a laser-scanning confocal micro-
scope (Radiance 2100 Rainbow; Bio-Rad Laboratories) with a 100× oil 
objective lens (Carl Zeiss MicroImaging, Inc.). For CD1d and Lamp-1 co-
localization studies, after fi  xation with 3.7% formaldehyde for 15 min, cells 
were quenched for 10 min with 50 mM NH4Cl in PBS and blocked with 
4% FBS, 0.5% BSA, and 0.1% saponin in PBS for 30 min. Cells were incu-
bated with a rat monoclonal anti-CD1d antibody (16G9; reference 51) in 4% 
FBS, 0.5% BSA, and 0.1% saponin in PBS for 60 min, washed with PBS, 
and incubated with a Texas red-X–conjugated goat anti–rat IgG antibody 
(Invitrogen). Cells were washed three times with PBS and incubated with 
a FITC-conjugated rat monoclonal anti–Lamp-1 antibody (BD Biosciences) 
in 4% FBS, 0.5% BSA, and 0.1% saponin in PBS for 60 min. Stained cells 
were mounted on slides with Mowiol (EMD Bioscience) and analyzed by 
confocal microscopy.
NPC2 and GM2a production/purifi  cation. Recombinant mouse NPC2 
was expressed in a fl  y expression system (40). In brief, mouse NPC2 cDNA 
was subcloned into the expression vector pRMHa-3, and an N-terminal 
histidine tag was incorporated. Cells were cultured in roller bottles, and 
NPC2 protein was purifi  ed from the media using nickel-NTA agarose beads 
(QIAGEN) after tangential fl  ow concentration. The protein was purifi  ed 
using a MonoS column (GE Healthcare) to further remove contaminating 
proteins and applied to a Superdex 200 column (GE Healthcare) to separate 
the dimer from the monomer form of NPC2. Fractions containing mono-
mers only or enriched with the dimer forms of NPC2 were pooled and used 
for in vitro loading or activation assays. Mouse GM2a was produced using a 
similar approach and was purifi  ed by combination nickel-NTA agarose-ion 
exchange chromatography.
In vitro CD1d-loading assay. Recombinant mouse CD1d was ex-
pressed in a fl  y expression system (40). Purifi  ed complexes of CD1d–GT1b 
were used to study the exchange of lipid into CD1d (21, 42). 2 μM 
mCD1d–GT1b was incubated with various concentrations of NPC2 dimers 
and in the presence or absence of GM3 or iGb3. Lipid unloading and loading JEM VOL. 204, April 16, 2007  851
ARTICLE
into CD1d were visualized using IEF gel and were quantifi  ed  using 
UN-SCAN-IT gel digitizing software (Silk Scientifi  c; references 10, 21). 
The percentages were calculated as follows: percentage of GM3 loading 
into CD1d = (CD1d–GM3/(CD1d–GM3 + CD1d–GT)) × 100. Per-
centage of GT1b unloading = (CD1d unloaded/(CD1d unloaded + 
CD1d–GT1b)) × 100.
RNA extraction and semiquantitative PCR. Fresh thymocytes and 
splenocytes from NPC2−/− and WT mice were obtained as previously de-
scribed (32, 33). Cells were washed with cold PBS, and total RNA was iso-
lated using TRIzol reagent (Invitrogen). cDNA were generated using 1 μg of 
total RNA and the Superscript III First-Strand synthesis system (Invitrogen). 
NPC2 and actin (used as an internal control) mRNA were amplifi  ed by 
PCR, and the products were visualized using agarose gel.
Expression of NPC2 in thymocytes. To test the expression of NPC2 in 
WT thymocytes and splenocytes, cells were washed with PBS and lysed by 
incubation for 30 min at room temperature in lysis buff  er (60 mM Tris, pH 
7.5, 150 mM NaCl, 2% SDS, and 1 U benzonase). Samples were resolved 
using 10–20% Tris-HCl precasted gels (Bio-Rad Laboratories). Proteins 
were electroblotted onto 0.2-μm polyvinylidene difl  uoride membranes, and 
membranes were blocked for 1 h with 10% FBS and 0.2% Triton X-100 in 
PBS. The membranes were then incubated for 1 h at room temperature with 
anti-NPC2 antibody (dilution of 1:250; polyclonal rabbit anti-NPC2 serum; 
gift from P. Lobel, Rutgers University, Piscataway, NJ). The blots were 
washed three times for 10 min with 0.2% Tween 20 in PBS and incubated 
for 1 h with peroxidase-labeled anti–rabbit immunoglobulin (dilution of 
1:5,000; GE Healthcare). Blots were developed using SuperSignal (Pierce 
Chemical Co.).
Expression of NPC2 in HeLa cells. The mouse NPC2 cDNA was sub-
cloned into the expression vector pcDNA3 with an N-terminal Flag tag. 
Cells were transiently transfected using LipofectAMINE (Invitrogen). 24 h 
after transfection, cells were washed with PBS and lysed by incubation for 
30 min on ice with lysis buff  er (50 mM Hepes, 100 mM NaCl, 10% glycerol, 
and 0.5% NP-40). Lysates were left untreated or were boiled for 5 min in the 
presence of 1% SDS and resolved using 10–20% Tris-HCl precasted gels. 
Proteins were detected by Western blotting using a monoclonal anti-Flag 
antibody (Sigma-Aldrich).
Cholesterol-binding assay. For binding measurements, NPC2 and DHE 
(Sigma-Aldrich) were diluted in PBS and incubated for 30 min at 25°C in 
the dark. 200-μl samples in quartz microcells were excited at 338 nm with a 
0.5-nm bandpass slit. Emission spectra were obtained from 345 to 470 nm 
with a 4-nm bandpass slit. Fluorescence spectra were recorded by using a 
luminescence spectrometer (LS55; PerkinElmer).
Online supplemental material. Fig. S1 shows CD4+ and CD8+ T 
cells in the thymus and spleen and B cells in the spleen. Fig. S2 shows the 
  thymic NKT cell phenotype in WT and NPC2−/− mice. Fig. S3 shows 
the expression of CD1d on thymocytes, splenocytes, and BMDCs from 
WT, NPC2−/−, and CD1d−/− mice. Fig. S4 shows the expression of NPC2 
in thymocytes and splenocytes. Fig. S5 shows cholesterol storage in WT 
and NPC2−/− cells. Fig. S6 shows the traffi   cking of a fl  uorescent-labeled 
  derivative of αGalCer in WT and NPC2−/− primary skin fi  broblasts. Fig. S7 
shows that exogenous NPC2 protein enhances the presentation of αGalCer 
by splenocytes from WT and NPC2−/− mice. Fig. S8 shows a schematic 
representation of the structures of iGb3 C8, iGb3 C18, and PBS-81. Online 
supplemental material is available at http://www.jem.org/cgi/content/full/
jem.20061562/DC1.
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